GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » Cyclically Adjusted Book per Share

Duopharma Biotech Bhd (XKLS:7148) Cyclically Adjusted Book per Share : RM0.65 (As of Sep. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Duopharma Biotech Bhd's adjusted book value per share for the three months ended in Sep. 2023 was RM0.701. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is RM0.65 for the trailing ten years ended in Sep. 2023.

During the past 12 months, Duopharma Biotech Bhd's average Cyclically Adjusted Book Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-04-30), Duopharma Biotech Bhd's current stock price is RM1.17. Duopharma Biotech Bhd's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was RM0.65. Duopharma Biotech Bhd's Cyclically Adjusted PB Ratio of today is 1.80.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Duopharma Biotech Bhd was 4.44. The lowest was 1.73. And the median was 2.37.


Duopharma Biotech Bhd Cyclically Adjusted Book per Share Historical Data

The historical data trend for Duopharma Biotech Bhd's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd Cyclically Adjusted Book per Share Chart

Duopharma Biotech Bhd Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.54 0.61

Duopharma Biotech Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.61 0.62 0.64 0.65

Competitive Comparison of Duopharma Biotech Bhd's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Duopharma Biotech Bhd's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Duopharma Biotech Bhd's Cyclically Adjusted PB Ratio falls into.



Duopharma Biotech Bhd Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Duopharma Biotech Bhd's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book= Book Value per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0.701/129.8595*129.8595
=0.701

Current CPI (Sep. 2023) = 129.8595.

Duopharma Biotech Bhd Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.313 98.326 0.413
201403 0.328 99.695 0.427
201406 0.309 100.560 0.399
201409 0.324 100.428 0.419
201412 0.332 99.070 0.435
201503 0.351 99.621 0.458
201506 0.327 100.684 0.422
201509 0.516 100.392 0.667
201512 0.518 99.792 0.674
201603 0.527 100.470 0.681
201606 0.515 101.688 0.658
201609 0.522 101.861 0.665
201612 0.524 101.863 0.668
201703 0.535 102.862 0.675
201706 0.533 103.349 0.670
201709 0.546 104.136 0.681
201712 0.553 104.011 0.690
201803 0.565 105.290 0.697
201806 0.551 106.317 0.673
201809 0.567 106.507 0.691
201812 0.545 105.998 0.668
201903 0.564 107.251 0.683
201906 0.556 108.070 0.668
201909 0.557 108.329 0.668
201912 0.581 108.420 0.696
202003 0.575 108.902 0.686
202006 0.620 108.767 0.740
202009 0.631 109.815 0.746
202012 0.684 109.897 0.808
202103 0.679 111.754 0.789
202106 0.652 114.631 0.739
202109 0.650 115.734 0.729
202112 0.663 117.630 0.732
202203 0.667 121.301 0.714
202206 0.670 125.017 0.696
202209 0.676 125.227 0.701
202212 0.688 125.222 0.713
202303 0.695 127.348 0.709
202306 0.701 128.729 0.707
202309 0.701 129.860 0.701

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Duopharma Biotech Bhd  (XKLS:7148) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Duopharma Biotech Bhd's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.17/0.65
=1.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Duopharma Biotech Bhd was 4.44. The lowest was 1.73. And the median was 2.37.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Duopharma Biotech Bhd Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Duopharma Biotech Bhd (XKLS:7148) Business Description

Traded in Other Exchanges
N/A
Address
Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, MYS, 41200
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd (XKLS:7148) Headlines

No Headlines